Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Guerzoni

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cephalalgia : an International Journal of Headache|April 23, 2025
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study)Fabrizio Vernieri, Luigi Francesco Iannone, Flavia Lo Castro, et al.
European Journal of Neurology|September 17, 2024
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort studyLuigi Francesco Iannone, Marina Romozzi, Antonio Russo, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Cephalalgia : an International Journal of Headache|November 26, 2024
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional studyGiorgio Dalla Volta, Antonio Russo, Marcello Silvestro, et al.
Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
CNS Drugs|November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort StudyValeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Frontiers in Neurology|September 22, 2025
Sex differences in the clinical features of 2,841 patients with migraine: a <i>post-hoc</i>, multicenter, cross-sectional studyMarina Romozzi, Luigi Francesco Iannone, Marcello Silvestro, et al.
Frontiers in Neurology|January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in MenRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cephalalgia : an International Journal of Headache|April 23, 2025
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study)Fabrizio Vernieri, Luigi Francesco Iannone, Flavia Lo Castro, et al.
European Journal of Neurology|September 17, 2024
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort studyLuigi Francesco Iannone, Marina Romozzi, Antonio Russo, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Cephalalgia : an International Journal of Headache|November 26, 2024
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional studyGiorgio Dalla Volta, Antonio Russo, Marcello Silvestro, et al.
Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
CNS Drugs|November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort StudyValeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Frontiers in Neurology|September 22, 2025
Sex differences in the clinical features of 2,841 patients with migraine: a <i>post-hoc</i>, multicenter, cross-sectional studyMarina Romozzi, Luigi Francesco Iannone, Marcello Silvestro, et al.
Frontiers in Neurology|January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in MenRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
Pageof 8